Transient familial neonatal hyperbilirubinemia

Transient familial neonatal hyperbilirubinemia, also known as Lucey-Driscoll syndrome or transient familial hyperbilirubinemia, is a rare inherited condition characterized by severe unconjugated (indirect) hyperbilirubinemia appearing in the first few days of life. The condition is caused by the presence of an inhibitor of hepatic glucuronyl transferase activity, believed to be a substance (possibly a pregnane steroid) present in maternal serum that is transferred to the infant. This inhibitor impairs the normal conjugation of bilirubin in the newborn's liver, leading to a dangerous accumulation of unconjugated bilirubin in the blood. The condition primarily affects the hepatic (liver) system and, if untreated, can lead to kernicterus — a form of brain damage caused by excessive bilirubin crossing the blood-brain barrier and depositing in the basal ganglia and brainstem nuclei. Clinical features include marked jaundice (yellowing of the skin and eyes) within the first days of life, with bilirubin levels that can rise to dangerously high concentrations. The condition is termed 'transient' because the inhibitory factor is cleared from the infant's circulation over time, and the hyperbilirubinemia resolves spontaneously as the substance is metabolized. Treatment focuses on preventing kernicterus through aggressive management of hyperbilirubinemia. Phototherapy is the first-line treatment, using specific wavelengths of light to convert unconjugated bilirubin into water-soluble isomers that can be excreted. In severe cases, exchange transfusion may be necessary to rapidly reduce bilirubin levels. With prompt recognition and appropriate treatment, the prognosis is generally good, and affected infants typically recover without long-term sequelae. Importantly, the condition tends to recur in subsequent pregnancies of the same mother, which is a key diagnostic clue.

Common questions about Transient familial neonatal hyperbilirubinemia